Adi Sarana Armada Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Adi Sarana Armada Tbk trades at Rp615 (market cap 2.31T, 4.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Adi Sarana Armada Tbk is far larger — about 14× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Adi Sarana Armada Tbk is more actively traded (4.47M versus 187.4K). Which is the better fit depends on your goals.
| ASSA | OBAT | |
|---|---|---|
Market Cap | 2.31T | 164.65B |
Volume | 4.47M | 187.4K |
Lot | 44.71K | 1.87K |
Turnover | 2.77B | 44.35M |
Average Price | 618.59 | 236.67 |
Value | 2.77B | 44.35M |
Indicative Equilibrium Price | 615 | 242 |
Indicative Equilibrium Volume | 663 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Adi Sarana Armada (the Company) was established in the Republic of Indonesia on December 17, 1999 based on the Notarial Deed no.56 of Misahardi Wilamarta, S.H. The Company's Articles of Association have been amended several times, the latest of which was covered by Notarial Deed no.11 of Liliek Zaenah, S.H., dated June 26, 2012, about the change in the Company's shareholders.
Read more on ASSA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →